氯吡格雷联合阿托伐他汀钙治疗脑梗塞的临床效果研究
Clinical effect of clopidogrel combined with atorvastatin calcium in the treatment of cerebral infarction
ES评分 0
| DOI |
10.12208/j.ijcr.20220454 |
| 刊名 |
International Journal of Clinical Research
|
| 年，卷(期) |
2022, 6(9) |
| 作者 |
|
| 作者单位 |
馆陶县人民医院 河北邯郸 ;
|
| 摘要 |
分析在对脑梗塞患者实施治疗期间联合氯吡格雷、阿托伐他汀钙的意义。方法 本项研究中入组100例患者均为我院神经内科在2019年1月到2020年1月间收治并确诊患者，按照随机数字表法将50例归到对照组、将另外50例归到观察组，分别予以氯吡格雷治疗、联合阿托伐他汀钙治疗。观察并总结两组治疗效果，实施相关指标对比分析。结果 治疗前，两组血脂、神经功能缺损，及斑块面积、厚度的数值对比无差异，P＞0.05；治疗后虽均有改善，但明显观察组由于对照组，且组间对比差异显著，P＜0.05。结论 在对脑梗塞患者实施治疗期间联合氯吡格雷、阿托伐他汀钙可促进患者病态机体的快速改善。
|
| Abstract |
Objectives: To analyze the significance of clopidogrel combined with atorvastatin calcium in the treatment of cerebral infarction patients. Methods: the 100 patients enrolled in this study were all patients admitted and diagnosed by the Department of Neurology of our hospital from January 2019 to January 2020. According to the random number table method, 50 patients were assigned to the control group and the other 50 patients to the observation group. They were treated with clopidogrel and atorvastatin calcium respectively. Observe and summarize the treatment effects of the two groups, and carry out comparative analysis of relevant indicators. Results: before treatment, there was no difference in blood lipid, neurological deficit, plaque area and thickness between the two groups (P > 0.05); Although there were improvements after treatment, it was obvious that the observation group was different from the control group, and the difference between the two groups was significant (P < 0.05). Conclusion: the combination of clopidogrel and atorvastatin calcium during the treatment of cerebral infarction patients can promote the rapid improvement of the sick body of patients.
|
| 关键词 |
氯吡格雷；阿托伐他汀钙；脑梗塞；血脂；神经功能缺损
|
| KeyWord |
clopidogrel; Atorvastatin calcium; Cerebral infarction; Blood lipids; Neurological deficit
|
| 基金项目 |
|
| 页码 |
138-140 |
韩兆强*.
氯吡格雷联合阿托伐他汀钙治疗脑梗塞的临床效果研究 [J].
国际临床研究杂志.
2022; 6; (9).
138 - 140.